{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:48:05Z","timestamp":1781002085899,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13304-025-02104-5","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T14:29:17Z","timestamp":1737296957000},"page":"277-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Colon and rectal peritoneal carcinomatosis: are we mixing apples with oranges? A propensity score-matched analysis"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-1324","authenticated-orcid":false,"given":"Carlo","family":"Vallicelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Morezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Perrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fugazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Pinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Vigutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Tuech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"issue":"3","key":"2104_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"2104_CR2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21037\/atm.2019.07.91","volume":"7","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Sanchis-Gomar F, Lippi G (2019) Concise update on colorectal cancer epidemiology. Ann Transl Med 7(21):609","journal-title":"Ann Transl Med"},{"issue":"3","key":"2104_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2023) Colorectal cancer statistics. Cancer J Clin 73(3):233\u2013254","journal-title":"Cancer J Clin"},{"issue":"1","key":"2104_CR4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics. Cancer J Clin 74(1):12\u201349","journal-title":"Cancer J Clin"},{"issue":"11","key":"2104_CR5","doi-asserted-by":"crossref","first-page":"e2243119","DOI":"10.1001\/jamanetworkopen.2022.43119","volume":"5","author":"Rottoli M, Gori A, Pellino G, Flacco ME, Martellucci C, Spinelli A, Poggioli G, COVID\u2013Colorectal Cancer (CRC) Study Group","year":"2022","unstructured":"Rottoli M, Gori A, Pellino G, Flacco ME, Martellucci C, Spinelli A, Poggioli G, COVID\u2013Colorectal Cancer (CRC) Study Group (2022) Colorectal cancer stage at diagnosis before vs during the COVID-19 pandemic in Italy. JAMA Netw Open 5(11):e2243119","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2104_CR6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-021-02374-4","volume":"19","author":"H Chen","year":"2021","unstructured":"Chen H, Zhou S, Bi J et al (2021) Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? World J Surg Oncol 19(1):253","journal-title":"World J Surg Oncol"},{"issue":"1","key":"2104_CR7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1245\/s10434-023-14368-5","volume":"31","author":"M H\u00fcbner","year":"2024","unstructured":"H\u00fcbner M, van Der Speeten K, Govaerts K et al (2024) 2022 peritoneal surface oncology group international consensus on HIPEC regimens for peritoneal malignancies: colorectal cancer. Ann Surg Oncol 31(1):567\u2013576","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2104_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L et al (2021) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(2):256\u2013266","journal-title":"Lancet Oncol"},{"issue":"6","key":"2104_CR9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","volume":"257","author":"D Goer\u00e9","year":"2013","unstructured":"Goer\u00e9 D, Malka D, Tzanis D et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complte cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065\u20131071","journal-title":"Ann Surg"},{"key":"2104_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fonc.2019.00076","volume":"9","author":"CB Wang","year":"2019","unstructured":"Wang CB, Shahjehan F, Merchea A et al (2019) Impact of tumor location and variables associated with overall survival in patients with colorectal cancer: a mayo clinic colon and rectal cancer registry study. Front Oncol 9:76","journal-title":"Front Oncol"},{"issue":"1","key":"2104_CR11","doi-asserted-by":"crossref","first-page":"100014","DOI":"10.1016\/j.soi.2024.100014","volume":"1","author":"T Violante","year":"2024","unstructured":"Violante T, Ferrari D, Day CN et al (2024) The effect of the pandemic on colorectal cancer in the United States: an increased disease burden. Surg Oncol Insight 1(1):100014","journal-title":"Surg Oncol Insight"},{"issue":"6","key":"2104_CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12032-016-0772-6","volume":"33","author":"M P\u0119dziwiatr","year":"2016","unstructured":"P\u0119dziwiatr M, Pisarska M, Kisielewski M et al (2016) ERAS protocol in laparoscopic surgery for colonic versus rectal carcinoma: are there differences in short-term outcomes? Med Oncol Northwood Lond Engl 33(6):56","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"5","key":"2104_CR13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jso.24169","volume":"113","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Braam HJ et al (2016) Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study. J Surg Oncol 113(5):548\u2013553","journal-title":"J Surg Oncol"},{"issue":"2","key":"2104_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/JCRP.JCRP_32_21","volume":"9","author":"HH Yu","year":"2022","unstructured":"Yu HH, Hsieh MC, Su BC (2022) Comparison of survival outcomes using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colon versus rectal cancer with peritoneal carcinomatosis in an Asian medical center. J Cancer Res Pract 9(2):59","journal-title":"J Cancer Res Pract"},{"issue":"5","key":"2104_CR15","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1245\/s10434-019-07255-5","volume":"26","author":"KJ Kelly","year":"2019","unstructured":"Kelly KJ, Alsayadnasser M, Vaida F et al (2019) Does primary tumor side matter in patients with metastatic colon cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol 26(5):1421\u20131427","journal-title":"Ann Surg Oncol"},{"issue":"9596","key":"2104_CR16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453\u20131457","journal-title":"Lancet"},{"issue":"1","key":"2104_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25(1):1\u201321","journal-title":"Stat Sci"},{"key":"2104_CR18","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s11605-023-05833-3","volume":"27","author":"H Benvenisti","year":"2023","unstructured":"Benvenisti H, Shiber M, Assaf D et al (2023) Perioperative and Oncological outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of rectal origin. J Gastrointest Surg 27:2506\u20132514","journal-title":"J Gastrointest Surg"},{"key":"2104_CR19","doi-asserted-by":"crossref","first-page":"LBA3504","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA3504","volume":"41","author":"T Conroy","year":"2023","unstructured":"Conroy T, Etienne PL, Rio E et al (2023) Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial. J Clin Oncol 41:LBA3504","journal-title":"J Clin Oncol"},{"key":"2104_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22:29\u201342","journal-title":"Lancet Oncol"},{"key":"2104_CR21","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","volume":"40","author":"J Jin","year":"2022","unstructured":"Jin J, Tang Y, Hu C et al (2022) Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 40:1681\u20131692","journal-title":"J Clin Oncol"},{"key":"2104_CR22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/ijms18061324","volume":"18","author":"A Passardi","year":"2017","unstructured":"Passardi A, Canale M, Valgiusti M et al (2017) Immune checkpoints as a target for colorectal cancer treatment. Int J Mol Sci 18:1324","journal-title":"Int J Mol Sci"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02104-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T18:31:43Z","timestamp":1743705103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02104-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,19]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02104-5","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,19]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no competing interest nor source of funding to declare.\u00a0Raw data\u00a0are not publicly available to preserve individuals\u2019 privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards, disclosure of potential conflicts of interest, research involving human participant<!--Too long, content removed-->"}}]}}